Of all the mucins, MUC16, the most widely known mucin originally identified as CA125 antigen and a promising biomarker in ovarian cancer, is overexpressed in 60–80% of PC and NSCLC patients16. This evidence concerns the gene MUC16 and pachyonychia congenita.